Kerry Sivia is a patient advocate living with metabolic dysfunction–associated steatotic liver disease (MASLD/MASH), autoimmune hepatitis, primary biliary cholangitis (PBC), and cirrhosis. Since receiving her diagnoses in 2021, she has become a leading voice for patient-centered advocacy in hepatology care, focusing on multidisciplinary collaboration, health equity, and the lived experience of people affected by liver disease.
I am a gastroenterologist and hepatologist at Yale School of Medicine with a research focus on decision science in liver cancer screening and gene-environment interactions that influence liver cancer risk.
Dr. Mamatha Bhat is a Hepatologist and leads the Transplant AI initiative at the University Health Network's Ajmera Transplant Centre, and Associate Professor of Medicine at the University of Toronto. Dr. Bhat completed her medical school and residency training at McGill University. She then completed a Transplant Hepatology fellowship at the Mayo Clinic in Rochester, Minnesota, followed by a Canadian Institutes of Health Research (CIHR) Fellowship for Health Professionals, through which she completed a PhD.
Whitney Steinmetz is a board-certified family nurse practitioner who provides patient-focused, evidence-based care in gastroenterology and hepatology. She has a passion for improving access to care in rural healthcare environments. Dr. Steinmetz earned her bachelor's of science degree with honors, Magna Cum Laude, at the University of Arizona.
Allysa Saggese is a graduate of Columbia University School of Nursing and is an ANCC Board Certified Adult Gerontology Primary Care Nurse Practitioner currently specializing in hepatology and research at Weill Cornell Medicine in New York City.
Manal H El-Sayed (MD, MSc and PhD Pediatrics)
Ain Shams University, Egypt
Dr. Manal El-Sayed (Cairo, Egypt) is Professor of Pediatrics at Ain Shams University, former Chair of the Pediatric Department, and founder and former director of the clinical research center (MASRI-CRC) and co-supervisor of the viral hepatitis treatment center at the Faculty of Medicine, Ain Shams University. She is also the clinical director of the national HCV Pediatric treatment program.
Harry L.A. Janssen graduated from medical school in Nijmegen, Netherlands. During his study he spent one year as research fellow in Hepatology at the Mayo Clinic. He obtained his PhD at the Erasmus University in Rotterdam on the role of immune modulating therapy in chronic hepatitis B. Following his training in Internal Medicine in Leiden and Gastroenterology at the Erasmus University in Rotterdam, he returned to the Mayo Clinic for a Research Fellowship in Hepatology at the Center of Basic Research in Digestive Diseases.
Peyton Thompson, MD, MSCR, is an Assistant Professor and Program Director of Pediatric Infectious Diseases at the University of North Carolina at Chapel Hill, where she has been on faculty since 2019. Peyton's research interests focus broadly on the promotion of infant health in low-resource settings through vaccination, with a particular interest in hepatitis.
Doan Y Dao, MD, is a hepatologist and physician-scientist at Massachusetts General Hospital and a faculty member at Harvard Medical School. His work focuses on chronic hepatitis B and hepatocellular carcinoma, integrating longitudinal hepatitis cohorts, translational biomarker research, and clinical investigation to advance precision prevention and early detection of HBV-related liver cancer. His research is supported by the National Institutes of Health, the U.S. Department of Defense, industry partners, and foundations.